---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-259009"
form_type: "8-K"
ticker: "BMRN"
cik: "0001048477"
company_name: "BIOMARIN PHARMACEUTICAL INC"
filed_at: "2022-10-07T23:59:59+00:00"
generated_at: "2026-06-23T04:37:39.889961+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# BioMarin cuts ~120 jobs, expects $50M annual savings to reinvest

## Summary
- Workforce reduction of ~120 employees; pre-tax charges of $20-25M in Q3/Q4 2022.
- Expected annualized cost savings ~$50M; savings to be reinvested in operations to boost profitability.
- Majority of reductions announced Oct 6, 2022; substantially complete by Dec 31, 2022.

## SEC filing metadata
- accession: 0001193125-22-259009
- form_type: 8-K
- ticker: BMRN
- cik: 0001048477
- company_name: BIOMARIN PHARMACEUTICAL INC
- filed_at: 2022-10-07T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.05
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1048477/000119312522259009/0001193125-22-259009-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1048477/000119312522259009/d383407d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-259009
- JSON: https://secwatch.observer/filing/0001193125-22-259009.json
- Plain text: https://secwatch.observer/filing/0001193125-22-259009.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.